Associations between palliative-care consultations and end-of-life quality in cancer patients' last 6 months
- PMID: 39168868
- DOI: 10.1007/s00520-024-08814-7
Associations between palliative-care consultations and end-of-life quality in cancer patients' last 6 months
Abstract
Purpose: Improving end-of-life (EOL) quality for terminally ill cancer patients is crucial. However, associations between hospice/palliative care and EOL quality, as perceived by patients, are underreported. We aimed to examine the impact of palliative care consultative services on the EOL quality during cancer patients' last six months.
Methods: In this prospective, longitudinal study, 174 cancer patients were divided into a palliative care consultative services group (n = 65) or a non palliative care consultative services group (n = 109). The impact of palliative care consultative services on EOL quality, assessed using the Quality of Dying and Death (QODD) scale at the first and last assessments within the patients' last six months, was analyzed by linear regression with generalized estimating equations, adjusting for covariates.
Results: Cancer patients received palliative care consultative services a median of 34.0 days before death. There were significant main effects of groups, indicating that patients receiving palliative care consultative services had better QODD total scores (β [95% confidence interval] = 2.12 [0.32,3.93], p = .021), death preparation (3.80 [1.71,5.89], p < .001), and treatment preferences than the reference group (3.27 [0.90,5.64], p = .007). No group differences were found in other dimensions, including symptom and personal care, whole person concern, and time with family.
Conclusion: Palliative care consultative services significantly improved cancer patients' perceptions of death preparation, treatment preferences, and the QODD total score. Therefore, healthcare professionals should offer palliative care consultative services to cancer patients, initiate early referrals for such care, and implement effective and individualized interventions to enhance EOL quality.
Keywords: Cancer; End-of-life quality; Hospice care; Neoplasms; Palliative care consultative services; Patient perspective study; Quality of Dying and Death Questionnaire.
© 2024. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.
References
-
- Bekelman JE, Halpern SD, Blankart CR, Bynum JP, Cohen J, Fowler R, Kaasa S, Kwietniewski L, Melberg HO, Onwuteaka-Philipsen B, Oosterveld-Vlug M, Pring A, Schreyögg J, Ulrich CM, Verne J, Wunsch H, Emanuel EJ, International Consortium for End-of-Life Research (ICELR) (2016) Comparison of site of death, health care utilization, and hospital expenditures for patients dying with cancer in 7 developed countries. JAMA 315(3):272–283. https://doi.org/10.1001/jama.2015.18603 - DOI - PubMed
-
- Teno JM, Gozalo P, Trivedi AN, Bunker J, Lima J, Ogarek J, Mor V (2018) Site of death, place of care, and health care transitions among US Medicare beneficiaries, 2000–2015. JAMA 320(3):264–271. https://doi.org/10.1001/jama.2018.8981 - DOI - PubMed - PMC
-
- Mitchell RJ, Delaney GP, Arnolda G, Liauw W, Phillips JL, Lystad RP, Harrison R, Braithwaite J (2024) Potentially burdensome care at the end-of-life for cancer decedents: a retrospective population-wide study. BMC Palliat Care 23(1):32. https://doi.org/10.1186/s12904-024-01358-x - DOI - PubMed - PMC
-
- Wright AA, Zhang B, Ray A, Mack JW, Trice E, Balboni T, Mitchell SL, Jackson VA, Block SD, Maciejewski PK, Prigerson HG (2008) Associations between end-of-life discussions, patient mental health, medical care near death, and caregiver bereavement adjustment. JAMA 300(14):1665–1673. https://doi.org/10.1001/jama.300.14.1665 - DOI - PubMed - PMC
-
- Davis MP, Vanenkevort EA, Elder A, Young A, Correa Ordonez ID, Wojtowicz MJ, Ellison H, Fernandez C, Mehta Z, Behm B, Digwood G, Panikkar R (2023) The financial impact of palliative care and aggressive cancer care on end-of-life health care costs. Am J Hosp Palliat Care 40(1):52–60. https://doi.org/10.1177/10499091221098062 - DOI - PubMed
MeSH terms
Grants and funding
- MOST 109-2314-B-227-001; MOST 110-2314-B-227-008/National Science and Technology Council
- MOST 109-2314-B-227-001; MOST 110-2314-B-227-008/National Science and Technology Council
- MOST 109-2314-B-227-001; MOST 110-2314-B-227-008/National Science and Technology Council
- MOST 109-2314-B-227-001; MOST 110-2314-B-227-008/National Science and Technology Council
LinkOut - more resources
Full Text Sources
Medical